Ligand validation:5MT3

SRO: SEROTONIN

SRO is a Ligand Of Interest in 5MT3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5MT3_SRO_I_101	78%	40%	0.105	0.947	1.09	1.23	-	1	0	0	100%	1
5MT3_SRO_d_102	77%	25%	0.116	0.955	1.4	1.65	2	5	0	0	100%	1
5MT3_SRO_G_101	75%	29%	0.111	0.943	1.3	1.52	1	2	0	0	100%	1
5MT3_SRO_W_101	72%	25%	0.126	0.95	1.37	1.68	1	2	0	0	100%	1
5MT3_SRO_a_101	69%	33%	0.106	0.92	1.53	1.14	3	-	0	0	100%	1
5MT3_SRO_O_101	64%	51%	0.138	0.938	1.1	0.8	1	-	0	0	100%	1
5MT3_SRO_S_101	53%	22%	0.146	0.907	1.3	1.93	2	2	0	0	100%	1
5MT3_SRO_C_101	51%	38%	0.15	0.903	1.15	1.29	2	2	0	0	100%	1
5MT3_SRO_E_102	28%	30%	0.261	0.913	1.24	1.56	1	2	0	0	100%	0.5
5MT3_SRO_c_101	8%	15%	0.323	0.796	1.35	2.4	-	4	0	0	100%	0.5
5MT3_SRO_K_101	3%	40%	0.366	0.691	1.09	1.24	-	1	0	0	100%	0.5
5MT3_SRO_Q_101	1%	31%	0.375	0.567	1.23	1.5	1	1	0	0	100%	0.5
5MAM_SRO_O_101	91%	33%	0.064	0.951	1.14	1.51	1	1	0	0	100%	1
5MT9_SRO_W_101	88%	34%	0.087	0.964	1.39	1.23	2	1	0	0	100%	1
2QEH_SRO_A_145	95%	16%	0.075	0.981	2.2	1.54	2	2	0	0	100%	1
8GDL_SRO_A_401	91%	41%	0.076	0.961	0.87	1.43	-	3	0	0	100%	1
2YMD_SRO_C_1213	90%	58%	0.082	0.965	0.88	0.75	-	-	1	0	100%	1
3BRN_SRO_A_158	89%	17%	0.103	0.982	2.09	1.56	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.